Legend Biotech annual debt-to-equity ratio
2020
2021
2022
2023
2024
2025
Legend Biotech Debt-to-Equity Ratio Growth & History (LEGN)
Legend Biotech's debt-to-equity ratio was 0.41 for fiscal 2025.
View full Legend Biotech company overviewLegend Biotech annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.41 | 0.13 | +43.48% |
| 2024 | 2024-12-31 | 0.29 | 0.05 | +21.09% |
| 2023 | 2023-12-31 | 0.24 | −0.13 | −35.36% |
| 2022 | 2022-12-31 | 0.37 | 0.21 | +130.40% |
| 2021 | 2021-12-31 | 0.16 | 0.15 | +2727.53% |
| 2020 | 2020-12-31 | 0.01 | — | — |
Legend Biotech quarterly debt-to-equity ratio
Q4.20
Q2.21
Q4.21
Q4.22
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.23 | −0.09 | −28.49% |
| Q1 2026 | 2026-03-31 | 0.40 | 0.10 | +33.34% |
| Q4 2025 | 2025-12-31 | 0.41 | 0.13 | +43.48% |
| Q3 2025 | 2025-09-30 | 0.41 | 0.14 | +50.94% |
| Q2 2025 | 2025-06-30 | 0.32 | 0.06 | +23.32% |
| Q1 2025 | 2025-03-31 | 0.30 | 0.05 | +17.74% |
| Q4 2024 | 2024-12-31 | 0.29 | 0.05 | +21.09% |
| Q3 2024 | 2024-09-30 | 0.27 | 0.05 | +22.21% |
| Q2 2024 | 2024-06-30 | 0.26 | 0.04 | +21.14% |
| Q1 2024 | 2024-03-31 | 0.26 | — | — |
| Q4 2023 | 2023-12-31 | 0.24 | −0.13 | −35.36% |
| Q3 2023 | 2023-09-30 | 0.22 | — | — |
| Q2 2023 | 2023-06-30 | 0.21 | — | — |
| Q4 2022 | 2022-12-31 | 0.37 | 0.21 | +130.40% |
| Q4 2021 | 2021-12-31 | 0.16 | 0.15 | +2727.53% |
| Q2 2021 | 2021-06-30 | 0.06 | — | — |
| Q4 2020 | 2020-12-31 | 0.01 | — | — |
Legend Biotech debt-to-equity ratio trends
Over the last five fiscal years, Legend Biotech's debt-to-equity ratio increased from 0.01 to 0.41, a change of 0.41. The latest reported quarter, Q2 2026, shows 0.23.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Legend Biotech source filings ↗